Get Free Delivery With No Minimum Order

FEXOFIN 180/MG TAB 30/TAB
- Sku : I-032073
Key features
Fexofin Film-coated tablet 180mg 30 Tabl is a film-coated tablet containing fexofenadine hydrochloride 180 mg. It acts as a selective peripheral H1‑receptor antagonist, blocking histamine at H1 receptors and exhibiting limited blood-brain barrier penetration. It is used to relieve symptoms of seasonal allergic rhinitis and to manage chronic idiopathic urticaria. Available OTC as film-coated tablets in a pack of 30.- Brand: FEXOFIN
- Active Ingredient: FEXOFENADINE HYDROCHLORIDE 180mg
- Strength: 180mg
- Dosage Form: Film-coated tablet
- Pack Size: 30 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Antiallergic
- Pharmacological Group: Other Antihistamines
- Drug Class: Second‑generation (non‑sedating) H1 antihistamine (peripheral H1‑receptor antagonist).
- Manufacturer: IND-SWIFT LIMITED
- Country of Origin: India
- SFDA Registration No.: 1-5362-19
- Shelf Life: 48 months
- Storage: store below 30°c
- Symptom Target: Allergy, Runny Nose, Itching
- Sedating: No
Indications
Approved Uses
Seasonal allergic rhinitis, chronic idiopathic urticaria
Dosage & Administration
Dosing by Condition
Seasonal allergic rhinitis (adults and children ≥12 years): 180mg once daily. Chronic idiopathic urticaria (adults and children ≥12 years): 180mg once daily. Children 6-11 years: 30mg twice daily (using 30mg or 60mg formulations)
Initial Dose
180mg once daily
Maintenance Dose
180mg once daily
Maximum Dose
180mg per day
Children's Dosage
Seasonal Allergic Rhinitis (6-11 years): 30mg twice daily. Chronic Idiopathic Urticaria (6-11 years): 30mg twice daily. (2-11 years): 30mg twice daily. (6 months-2 years): 15mg twice daily. The 180mg strength is not approved for children under 12 years.
Dose Adjustment Notes
Renal impairment: use a lower dose (commonly 60 mg once daily) in reduced renal function; no routine hepatic dose adjustment; avoid coadministration with fruit juices and separate Al/Mg antacids by ≥2 hours.
How to Take
Swallow the 180 mg film‑coated tablet whole with water; may be taken with or without food; avoid taking with fruit juices (apple/orange/grapefruit); if using Al/Mg antacids, separate by at least 2 hours.
Side Effects
Common Side Effects
Headache, nausea, dizziness, fatigue; less commonly drowsiness/somnolence, dyspepsia; may also include back pain and upper respiratory/viral infection symptoms.
Side Effect Frequency
Common (≥1% to <10%): headache, nausea, dizziness, somnolence/drowsiness; Uncommon (<1%): diarrhea, dry mouth, fatigue; Rare: palpitations/tachycardia, hypersensitivity reactions (e.g., angioedema/anaphylaxis)
Safety & Warnings
Contraindications
Hypersensitivity to fexofenadine (fexofenadine hydrochloride) or to any excipients in the product.
Warnings & Precautions
Use caution in renal impairment (consider lower starting dose); avoid/limit fruit juices that reduce absorption; discontinue and seek care if hypersensitivity occurs.
Age Restriction
For the 180 mg tablet: approved/appropriate for adults and adolescents ≥12 years; not recommended for children <12 years (use age-appropriate lower strengths/forms).
Drug Interactions
Drug Interactions
Antacids containing aluminum/magnesium reduce absorption (separate by ~2 hours); erythromycin/ketoconazole can increase fexofenadine exposure; fruit juices (apple/orange/grapefruit) reduce absorption-avoid or separate.
Interaction Severity
MODERATE: Aluminum/magnesium antacids (reduced absorption-separate by ≥2 hours); erythromycin or ketoconazole (increase fexofenadine exposure). MINOR to MODERATE (clinically relevant): fruit juices (reduced absorption-avoid).
Food Interaction
Take with water; avoid apple/orange/grapefruit juice (decreases absorption); may be taken with or without food (a high‑fat meal can reduce Cmax/AUC but usually not clinically significant for routine use).
Special Populations
Children
Seasonal Allergic Rhinitis (6-11 years): 30mg twice daily. Chronic Idiopathic Urticaria (6-11 years): 30mg twice daily. (2-11 years): 30mg twice daily. (6 months-2 years): 15mg twice daily. The 180mg strength is not approved for children under 12 years.
Kidney Impairment
Renal impairment: start with 60 mg once daily in adults/adolescents (including when using the 180 mg product, a lower-strength product is preferred); no adjustment is typically needed in mild impairment, but reduced starting dose is recommended in moderate-severe renal dysfunction.
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Stopping the Medicine
Safe to stop anytime
Overdose
Possible symptoms: dizziness, drowsiness/fatigue, dry mouth; management is symptomatic/supportive (consider decontamination if recent), and hemodialysis is not effective-seek medical attention/poison center guidance.
Patient Counseling
Take 1 tablet (180 mg) once daily with water; avoid fruit juices; may take with or without food; separate aluminum/magnesium antacids by ≥2 hours; usually non‑drowsy but use caution with driving until you know your response; stop several days before allergy skin testing if instructed; store below 30°C.
Monitoring Requirements
No routine monitoring required
Pharmacology
Mechanism of Action
Selective peripheral H1‑receptor antagonist that blocks histamine at H1 receptors; limited blood-brain barrier penetration, so sedation is minimal.
Onset of Action
Onset typically within ~1 hour (often 30-60 minutes), with peak effect around 2-3 hours.
Duration of Effect
24 hours
Half-Life
11-16 hours (mean ~14.4 hours)
Excretion
Eliminated largely unchanged, mainly via feces (~80%) with a smaller renal component (~10-11% in urine).
Product Information
Available Dosage Forms
For this SFDA-registered product: film‑coated tablet (oral) 180 mg only.
Composition per Dose
Each film-coated tablet: 180mg fexofenadine hydrochloride
Generic Availability
Yes
OTC Alternatives
Other OTC second‑generation antihistamines: cetirizine 10 mg, loratadine 10 mg, levocetirizine 5 mg.
Symptom Target
Allergy, Runny Nose, Itching
Sedating
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)





